These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Reversal of an inborn sphingolipidosis (Fabry's disease) by kidney transplantation. Philippart M; Franklin SS; Gordon A Ann Intern Med; 1972 Aug; 77(2):195-200. PubMed ID: 4565790 [No Abstract] [Full Text] [Related]
9. The biochemical abnormalities in Fabry's disease. Kint JA; Dacremont G Arch Int Physiol Biochim; 1970 Feb; 78(1):169-71. PubMed ID: 4100872 [No Abstract] [Full Text] [Related]
10. Presence of alpha-anomeric glycosidic configuration in the glycolipids accumulated in kidney with Fabry's disease. Handa S; Ariga T; Miyatake T; Yamakawa T J Biochem; 1971 Mar; 69(3):625-7. PubMed ID: 5551655 [No Abstract] [Full Text] [Related]
11. Letter: Enhancement of enzymatic activity in Fabry's disease. Christensen E N Engl J Med; 1974 Mar; 290(11):629-30. PubMed ID: 4204696 [No Abstract] [Full Text] [Related]
12. Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease. Brady RO; Tallman JF; Johnson WG; Gal AE; Leahy WR; Quirk JM; Dekaban AS N Engl J Med; 1973 Jul; 289(1):9-14. PubMed ID: 4196713 [No Abstract] [Full Text] [Related]
16. Angiokeratoma corporis diffusum (Fabry's disease) with renal, ocular and possibly cardiac involvement. Viskoper JR; Merin S Isr J Med Sci; 1970; 6(5):641-5. PubMed ID: 4923403 [No Abstract] [Full Text] [Related]
17. Anomeric structure of ceramide digalactoside isolated from the kidney of a patient with Fabry's disease. Li YT; Li SC; Dawson G Biochim Biophys Acta; 1972 Jan; 260(1):88-92. PubMed ID: 5012456 [No Abstract] [Full Text] [Related]